Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,753 public trials 829 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Recruiting

The TAIL-PrEP Study

NCT06868641

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital New York, United States
View Trial Details
Recruiting

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

NCT05218083

Conditions
COVID-19, Cardiorespiratory Fitness, Coronaviridae Infections, +16 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Kentucky Lexington, Kentucky, United States
  • Duke University Health System Durham, North Carolina, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Recruiting

Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections

NCT05147519

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +14 more
Locations
  • Kenya Medical Research Institute/ USAMRD-A/Kenya (Kericho) Kericho, Kericho County, Kenya
  • Clinical Research Centre, Walter Reed Army Institute of Research -Africa/Nigeria (WRAIR-A/Nigeria) Abuja, Nigeria
  • Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines Manila Manila, Philippines
  • Makerere University Walter Reed Program Makerere, Kampala, Uganda
View Trial Details
Recruiting

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease

NCT07220109

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Beijing, Beijing Municipality, China
  • GSK Investigational Site Xiangtan, Hunan, China
  • GSK Investigational Site Nanjing, Jiangsu, China
  • GSK Investigational Site Chengdu, Sichuan, China
View all 15 locations
View Trial Details

Related conditions